NATHBIOGENNSENath Bio-Genes (India) LimitedMediumNeutral
Announced Tue, 18 Nov · 17:17 IST

Nath Bio-Genes (India) Limited has informed the Exchange regarding 'Transcript of concall'.

Investor Communications View source PDF

NATHBIOGEN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Nath Bio-Genes (India) Limited has submitted the transcript of its recent conference call to the NSE. The filing itself does not contain the call's content — it only confirms that the transcript has been shared with the exchange. Investors can access the full transcript through the NSE/BSE portal or the company's investor relations page for detailed management commentary. Without the actual transcript content, no specific management statements, numbers, or guidance can be quoted here.

Likely market impact

Neutral, routine compliance filing. Investors should review the actual transcript to gauge any forward-looking commentary or guidance that could influence sentiment on the stock.